» Articles » PMID: 3997184

Identifiability Analysis of an in Vivo Receptor-binding Radiopharmacokinetic System

Overview
Date 1985 May 1
PMID 3997184
Citations 7
Authors
Affiliations
Soon will be listed here.
Citing Articles

Concepts for design and analysis of receptor radiopharmaceuticals: The Receptor-Binding Radiotracers series of meetings provided the foundation.

Krohn K, Vera D Nucl Med Biol. 2020; 92:5-23.

PMID: 32331709 PMC: 8049838. DOI: 10.1016/j.nucmedbio.2020.03.002.


Potential application of neogalactosylalbumin in positron emission tomography evaluation of liver function.

Du S, Li S, Jin B, Zhu Z, Dang Y, Xing H World J Gastroenterol. 2017; 23(23):4278-4284.

PMID: 28694668 PMC: 5483502. DOI: 10.3748/wjg.v23.i23.4278.


Measuring hepatic functional reserve using low temporal resolution Gd-EOB-DTPA dynamic contrast-enhanced MRI: a preliminary study comparing galactosyl human serum albumin scintigraphy with indocyanine green retention.

Saito K, Ledsam J, Sourbron S, Hashimoto T, Araki Y, Akata S Eur Radiol. 2013; 24(1):112-9.

PMID: 23949726 DOI: 10.1007/s00330-013-2983-y.


Scintigraphic evaluation of functional hepatic mass in patients with advanced breast cancer.

Virgolini I, Kornek G, Hobart J, Li S, Raolerer M, Bergmann H Br J Cancer. 1993; 68(3):549-54.

PMID: 8353045 PMC: 1968402. DOI: 10.1038/bjc.1993.384.


Estimation of remnant liver function before hepatectomy by means of technetium-99m-diethylenetriamine-pentaacetic acid galactosyl human albumin.

Yumoto Y, Umeda M, Ohshima K, Ogawa H, Kurokawa T, Kajitani M Cancer Chemother Pharmacol. 1994; 33 Suppl:S1-6.

PMID: 8137465 DOI: 10.1007/BF00686659.